Modifiable risk factor burden and the prevalence of peripheral artery disease in different vascular territories

被引:67
作者
Berger, Jeffrey S. [1 ,2 ]
Hochman, Judith [1 ]
Lobach, Iryna [3 ]
Adelman, Mark A. [2 ]
Riles, Thomas S. [2 ]
Rockman, Caron B. [2 ]
机构
[1] NYU, Sch Med, Dept Med, Div Cardiol,Langone Med Ctr, New York, NY 10016 USA
[2] NYU, Sch Med, Dept Surg, Div Vasc Surg,Langone Med Ctr, New York, NY 10016 USA
[3] NYU, Sch Med, Dept Populat Hlth, Div Biostat,Langone Med Ctr, New York, NY 10016 USA
关键词
HEART-DISEASE; ALL-CAUSE; MORTALITY; US; ASSOCIATIONS; REDUCTION; STATEMENT; UPDATE;
D O I
10.1016/j.jvs.2013.01.053
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: The precise relationship between risk factor burden and prevalence of peripheral artery disease (PAD) in different vascular territories (PAD, carotid artery stenosis [CAS], and abdominal aortic aneurysms [AAAs]) is unclear. Methods: We investigated the association of modifiable risk factors (hypertension, hypercholesterolemia, smoking, diabetes, and sedentary lifestyle) with any and type-specific peripheral vascular disease (PVD) among 3.3 million patients in the U. S., aged 40 to 99, who underwent screening bilateral ankle brachial indices, carotid duplex ultrasound, and abdominal aortic ultrasound in the Life Line Screening program between 2004 and 2008. Multivariate logistic regression analysis was used to estimate the odds of disease in different risk factor categories. Population-attributable risk was calculated to estimate the proportion of disease that could be potentially ascribed to modifiable risk factors. Results: Among 3,319,993 participants, prevalence of any PVD was 7.51% (95% confidence interval [CI], 7.50%-7.53%). PAD was present in 3.56% (95% CI, 3.54%-3.58%), CAS in 3.94% (95% CI, 3.92%-3.96%), and AAAs in 0.88% (95% CI, 0.86%-0.89%). The multivariate-adjusted prevalence with the presence of 0, 1, 2, 3, 4, and 5 modifiable risk factors was 2.76, 4.63, 7.12, 10.73, 16.00, and 22.08 (P < .0001 for trend) for any PVD; 1.18, 2.09, 3.28, 5.14, 8.32, and 12.43 (P < .0001 for trend) for PAD; 1.41, 2.36, 3.72, 5.73, 8.48, and 11.58 (P < .0001 for trend) for CAS; and 0.31, 0.54, 0.85, 1.28, 1.82, and 2.39 (P < .0001 for trend) for AAAs, respectively. These associations were similar for men and women. For every additional modifiable risk factor that was present, the multivariate-adjusted odds of having vascular disease increased significantly (any PVD [odds ratio (OR), 1.58; 95% CI, 1.58-1.59]; PAD [OR, 1.62; 95% CI, 1.621.63]; CAS [OR, 1.57; 95% CI, 1.56-1.57]; and AAA [OR, 1.51; 95% CI, 1.50-1.53]). Conclusions: This very large contemporary database demonstrates that risk factor burden is associated with an increased prevalence of PVD, and there is a graded association between the number of risk factors present and the prevalence of PAD, CAS, and AAAs.
引用
收藏
页码:673 / +
页数:10
相关论文
共 30 条
  • [1] [Anonymous], HLTH PEOPL 2020 ROAD
  • [2] Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults A Scientific Statement From the American Heart Association
    Artinian, Nancy T.
    Fletcher, Gerald F.
    Mozaffarian, Dariush
    Kris-Etherton, Penny
    Van Horn, Linda
    Lichtenstein, Alice H.
    Kumanyika, Shiriki
    Kraus, William E.
    Fleg, Jerome L.
    Redeker, Nancy S.
    Meininger, Janet C.
    Banks, JoAnne
    Stuart-Shor, Eileen M.
    Fletcher, Barbara J.
    Miller, Todd D.
    Hughes, Suzanne
    Braun, Lynne T.
    Kopin, Laurie A.
    Berra, Kathy
    Hayman, Laura L.
    Ewing, Linda J.
    Ades, Philip A.
    Durstine, J. Larry
    Houston-Miller, Nancy
    Burke, Lora E.
    [J]. CIRCULATION, 2010, 122 (04) : 406 - 441
  • [3] Low Prevalence of "Ideal Cardiovascular Health" in a Community-Based Population The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) Study
    Bambs, Claudia
    Kip, Kevin E.
    Dinga, Andrea
    Mulukutla, Suresh R.
    Aiyer, Aryan N.
    Reis, Steven E.
    [J]. CIRCULATION, 2011, 123 (08) : 850 - 857
  • [4] Diabetes and atherosclerosis - Epidemiology, pathophysiology, and management
    Beckman, JA
    Creager, MA
    Libby, P
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (19): : 2570 - 2581
  • [5] Screening for Cardiovascular Risk in Asymptomatic Patients
    Berger, Jeffrey S.
    Jordan, Courtney O.
    Lloyd-Jones, Donald
    Blumenthal, Roger S.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (12) : 1169 - 1177
  • [6] Smoking, Clopidogrel, and Mortality in Patients With Established Cardiovascular Disease
    Berger, Jeffrey S.
    Bhatt, Deepak L.
    Steinhubl, Steven R.
    Shao, Mingyuan
    Steg, P. Gabriel
    Montalescot, Gilles
    Hacke, Werner
    Fox, Keith A.
    Lincoff, A. Michael
    Topol, Eric J.
    Berger, Peter B.
    [J]. CIRCULATION, 2009, 120 (23) : 2337 - 2344
  • [7] Lifetime Risks of Cardiovascular Disease
    Berry, Jarett D.
    Dyer, Alan
    Cai, Xuan
    Garside, Daniel B.
    Ning, Hongyan
    Thomas, Avis
    Greenland, Philip
    Van Horn, Linda
    Tracy, Russell P.
    Lloyd-Jones, Donald M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04) : 321 - 329
  • [8] Atherosclerotic Peripheral Vascular Disease Symposium II Screening for Atherosclerotic Vascular Diseases: Should Nationwide Programs Be Instituted?
    Criqui, Michael H.
    Alberts, Mark J.
    Fowkes, Gerald R.
    Hirsch, Alan T.
    O'Gara, Patrick T.
    Olin, Jeffrey W.
    [J]. CIRCULATION, 2008, 118 (25) : 2830 - 2836
  • [9] Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease
    Diehm, Curt
    Allenberg, Jens Rainer
    Pittrow, David
    Mahn, Matthias
    Tepohl, Gerhart
    Haberl, Roman L.
    Darius, Harald
    Burghaus, Ina
    Trampisch, Hans Joachim
    [J]. CIRCULATION, 2009, 120 (21) : 2053 - U21
  • [10] Deaths Preventable in the US by Improvements in Use of Clinical Preventive Services
    Farley, Thomas A.
    Dalal, Mehul A.
    Mostashari, Farzad
    Frieden, Thomas R.
    [J]. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2010, 38 (06) : 600 - 609